Factores de riesgo en la aparición de multidrogo resistencia en pacientes con tuberculosis pulmonar / Risk factors in the emergence of multidrug resistance in patients with pulmonary tuberculosis
Rev. méd. panacea
;
4(2): 31-35, mayo-ago. 2014. tab, graf
Article
in Spanish
| LILACS
| ID: biblio-1024070
RESUMEN
Objetivo:
Identificar los factores de riesgo en la aparición de multidrogo resistencia en pacientes con tuberculosis en el Hospital Regional de Ica, durante los años 2006 al 2012. Materiales ymétodos:
La muestra estuvo constituida por 41 casos (tratados por tuberculosis multidrogo-resistente [TB-MDR]) y 82 controles (tratados por tuberculosis sensible [TB]), seleccionados mediante muestreo alea-torio sistemático.Resultados:
Se halló tuberculosis pulmonar en 92,7% de los casos y 80,5% de los con-troles; extrapulmonar en 22,4% de los casos y 15,9% de los controles y del tipo mixto en 2,4% en igual porcentaje tanto en los casos como en los controles (p>0,05). En 32 casos (78,0%) y 16 controles (19,5%) tenían antecedente de tratamiento antituberculoso (Chi2 =39.36; p=0,000; OR=14.24; IC95%=5,809-37,480). En 9 casos (22,2%) y 1 control (1,2%) se registró contacto previo con paciente diagnosticado de TB-MDR. (Chi2=13,08; p=0,000; OR=22,2; IC95%=3,451-508,8).Conclusiones:
La TB-MDR se presenta con mayor probabilidad cuando existe el antecedente de tratamiento antituberculoso y el contacto con un paciente que es portador de TB-MDR. (AU)ABSTRACT
Objective:
To identify risk factors in the emergence of multidrug resistance in tuberculosis patients in the Regional Hospital of Ica, during the years 2006 to 2012. Materials andMethods:
The sample con-sisted of 41 cases (treated for multidrug-resistant tuberculosis [TB-MDR]) and 82 controls (treated for sensitive tuberculosis [TB]), selected by systematic random sampling.Results:
Pulmonary tuberculosis was found in 92.7% of cases and 80.5% of controls; extrapulmonary in 22.4% of cases and 15.9% of controls and mixed type in 2.4% in the same proportion in both cases and controls (p> 0.05). In 32 cases (78.0%) and 16 controls (19.5%) had a history of TB treatment (Chi2 = 39.36; p = 0.000; OR = 14.24; 95% CI = 5.809 to 37.480). In 9 cases (22.2%) and control 1 (1.2%) prior contact with patients diagnosed with MDR-TB was recorded. (Chi2 = 13.08; p = 0.000; OR = 22.2; 95% CI = 3.451 to 508.8).Conclusions:
MDR-TB occurs most likely when the history of TB treatment and contact with a patient who is a carrier of MDR-TB exists. (AU)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Tuberculosis, Pulmonary
/
Risk Factors
/
Tuberculosis, Multidrug-Resistant
Type of study:
Controlled clinical trial
/
Etiology study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. panacea
Journal subject:
Medicine
Year:
2014
Type:
Article
Affiliation country:
Peru
Institution/Affiliation country:
Universidad Nacional San Luis Gonzaga/PE
Similar
MEDLINE
...
LILACS
LIS